论文部分内容阅读
目的分析临床凝血检验的合理性。方法 40例就诊和治疗出血倾向患者作为实验组,40例常规手术检查的手术患者作为对照组,取两组清晨静脉血进行凝血检验,对两组凝血指标与异常凝血结果占比进行分析。结果实验组与对照组活化部分凝血活酶时间(APTT)分别为(33.45±4.26)、(26.32±3.23)s,凝血酶时间(TT)分别为(16.25±1.94)、(14.23±1.42)s,纤维蛋白原(FIB)分别为(3.08±1.52)、(5.16±1.43)g/L,凝血酶原时间(PT)分别为(13.26±1.44)、(11.09±1.35)s,两组APTT、TT、FIB、PT比较差异均具有统计学意义(P<0.05)。实验组APTT异常率为85.0%、TT异常率为75.0%、FIB异常率为77.5%、PT异常率为77.5%,与对照组的5.0%、5.0%、2.5%、5.0%比较差异均具有统计学意义(P<0.05)。结论凝血四项在临床凝血检验中属于科学、合理的设置,临床应用价值极高。
Objective To analyze the rationality of clinical coagulation test. Methods 40 cases of patients with bleeding and treatment of bleeding as the experimental group, 40 cases of routine surgical examination of patients as control group, take two groups of early morning venous blood coagulation test, the coagulation index and the proportion of abnormal coagulation results were analyzed. Results The activated partial thromboplastin time (APTT) was (33.45 ± 4.26) and (26.32 ± 3.23) s in the experimental group and the control group respectively. The thrombin time (TT) were 16.25 ± 1.94 and 14.23 ± 1.42 s , Fibrinogen (FIB) were (3.08 ± 1.52) and (5.16 ± 1.43) g / L, respectively. Prothrombin time (PT) were 13.26 ± 1.44 and 11.09 ± 1.35, TT, FIB, PT were statistically significant differences (P <0.05). The abnormal rate of APTT in the experimental group was 85.0%, the abnormal rate of TT was 75.0%, the abnormal rate of FIB was 77.5%, the abnormal rate of PT was 77.5%, which was statistically different from 5.0%, 5.0%, 2.5% and 5.0% of the control group Significance (P <0.05). Conclusion The four coagulation tests belong to a scientific and reasonable setting in clinical coagulation tests and have high clinical value.